Bottom line
How much do XLV and VGHCX overlap?
53% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 61.7% of XLV's assets and 44.5% of VGHCX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings XLV and VGHCX have in common
| Holding | % of XLV | % of VGHCX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 16.51% | 8.61% | 8.61% |
| Johnson & Johnson | 10.64% | 4.83% | 4.83% |
| AbbVie Inc | 7.74% | 2.30% | 2.30% |
| UnitedHealth Group Inc | 6.57% | 4.05% | 4.05% |
| Merck & Co Inc | 5.52% | 5.44% | 5.44% |
| Intuitive Surgical Inc | 2.45% | 2.52% | 2.45% |
| CVS Health Corp | 2.30% | 2.52% | 2.30% |
| Vertex Pharmaceuticals Inc | 2.19% | 2.36% | 2.19% |
| Danaher Corp | 2.09% | 2.18% | 2.09% |
| Elevance Health Inc | 1.46% | 1.83% | 1.46% |
| Boston Scientific Corp | 1.10% | 1.53% | 1.10% |
| Regeneron Pharmaceuticals Inc | 1.08% | 2.14% | 1.08% |
| HCA Healthcare Inc | 1.05% | 1.68% | 1.05% |
| Cencora Inc | 0.96% | 2.47% | 0.96% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XLV
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Pfizer Inc — 2.39%
- Bristol-Myers Squibb Co — 2.05%
- Stryker Corp — 1.89%
- Medtronic PLC — 1.75%
- McKesson Corp — 1.58%
- Cigna Group/The — 1.27%
- Cardinal Health Inc — 0.97%
Only in VGHCX
- AstraZeneca PLC — 4.59%
- Gsk Plc — 3.00%
- Edwards Lifesciences Corp — 2.56%
- Novartis AG — 1.91%
- Argenx SE — 1.68%
- Ucb Sa — 1.67%
- Agilent Technologies Inc — 1.49%
- Biogen Inc — 1.46%
- Galderma Group AG — 1.37%
- Roche Holding AG — 1.18%
- Dexcom Inc — 1.18%
Asset mix
| Asset type | XLV | VGHCX |
|---|---|---|
| Stocks | 99.7% | 97.6% |
| Repurchase agreements | — | 2.2% |
| Cash & short-term funds | 0.3% | 0.1% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | XLV | VGHCX |
|---|---|---|
| US | 97.9% | 77.6% |
| GB | — | 7.6% |
| JP | — | 4.8% |
| CH | — | 4.5% |
| BE | — | 3.4% |
| IE | 2.1% | — |
| DK | — | 1.4% |
| HK | — | 0.8% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do XLV and VGHCX overlap?
What stocks do XLV and VGHCX have in common?
Should I own both XLV and VGHCX?
Which holds more stocks, XLV or VGHCX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.